MMP7 and renal pelvis/ureter urothelial carcinoma: Therefore, in this study, we assessed pre-treatment and post-/on-treatment serum MMP-7 levels of UTUC patients who underwent surgical or systemic (platinum-based or immune checkpoint inhibitor) treatment, and correlated the results with the patients’ clinicopathological and follow-up data.